Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

FEMS Yeast Research

Volumn 9, Issue 7, 2009, Pages 1029-1050

  Sanglard, Dominique ^a   Coste, Alix ^a   Ferrari, Sélène ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antifungal agents; Regulation; Resistance

Indexed keywords

ABC TRANSPORTER; AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CLOTRIMAZOLE; FENPROPIMORPH; FLUCONAZOLE; FLUCYTOSINE; GLYCOPROTEIN P; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NYSTATIN; POSACONAZOLE; TERBINAFINE; TOLNAFTATE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ASPERGILLUS; BINDING SITE; BIOFILM; CANDIDA; CATABOLISM; CGPDR1 GENE; CONTROL STRATEGY; DRUG TARGETING; FUNGAL GENE; GENE CONTROL; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; MRR1 GENE; NONHUMAN; PATHOGENESIS; SHORT SURVEY; TAC1 GENE; UPC2 GENE; UPREGULATION;

ANTIFUNGAL AGENTS; ASPERGILLUS; CANDIDA; DRUG RESISTANCE, FUNGAL; GENE EXPRESSION REGULATION;

ASPERGILLUS; CANDIDA; EUKARYOTA; FUNGI; HEXAPODA; MAMMALIA;

EID: 70350026151     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2009.00578.x     Document Type: Short Survey

References (172)

1. Alarco AM, Balan I, Talibi D, Mainville N Raymond M (1997) AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 272 : 19304 19313.
2. Arikan S (2007) Current status of antifungal susceptibility testing methods. Med Mycol 45 : 569 587.
3. Asai K, Tsuchimori N, Okonogi K, Perfect JR, Gotoh O Yoshida Y (1999) Formation of azole-resistant Candida albicans by mutation of sterol 14α-demethylase P450. Antimicrob Agents Ch 43 : 1163 1169.
4. Balan I, Alarco AM Raymond M (1997) The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter. J Bacteriol 179 : 7210 7218.
5. Barchiesi F, Calabrese D, Sanglard D et al 2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Ch 44 : 1578 1584.
6. Barker KS, Crisp S, Wiederhold N et al 2004) Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemoth 54 : 376 385.
7. Bennett JE, Izumikawa K Marr KA (2004) Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Ch 48 : 1773 1777.
8. Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM Koltin Y (1994) Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Ch 38 : 648 652.
9. Borecka-Melkusova S, Moran GP, Sullivan DJ, Kucharikova S, Chorvat D Jr. Bujdakova H (2009) The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole. Mycoses 52 : 118 128.
10. Brun S, Aubry C, Lima O, Filmon R, Berges T, Chabasse D Bouchara JP (2003) Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Ch 47 : 847 853.
11. Brun S, Berges T, Poupard P, Vauzelle-Moreau C, Renier G, Chabasse D Bouchara JP (2004) Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Ch 48 : 1788 1796.
12. Bruno VM Mitchell AP (2004) Large-scale gene function analysis in Candida albicans. Trends Microbiol 12 : 157 161.
13. Bruno VM Mitchell AP (2005) Regulation of azole drug susceptibility by Candida albicans protein kinase CK2. Mol Microbiol 56 : 559 573.
14. Bruno VM, Kalachikov S, Subaran R, Nobile CJ, Kyratsous C Mitchell AP (2006) Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog 2 : e21.
15. Calabrese D, Bille J Sanglard D (2000) A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146 : 2743 2754.
16. Canuto MM Rodero FG (2002) Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2 : 550 563.
17. Cao YY, Cao YB, Xu Z et al 2005) cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Ch 49 : 584 589.
18. Carvajal E, van den Hazel HB, Cybularz-Kolaczkowska A, Balzi E Goffeau A (1997) Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes. Mol Gen Genet 256 : 406 415.
19. Castano I, Kaur R, Pan S et al 2003) Tn7-based genome-wide random insertional mutagenesis of Candida glabrata. Genome Res 13 : 905 915.
20. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 : 5385 5394.
21. Chau AS, Gurnani M, Hawkinson R, Laverdiere M, Cacciapuoti A McNicholas PM (2005) Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans. Antimicrob Agents Ch 49 : 3646 3651.
22. Chen CG, Yang YL, Shih HI, Su CL Lo HJ (2004) CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Ch 48 : 4505 4512.
23. Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC Lo HJ (2009) Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Fungal Genet Biol 46 : 714 720.
24. Chen KH, Miyazaki T, Tsai HF Bennett JE (2007) The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. Gene 386 : 63 72.
25. Cleary JD, Garcia-Effron G, Chapman SW Perlin DS (2008) Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Ch 52 : 2263 2265.
26. Coste A, Turner V, Ischer F et al 2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172 : 2139 2156.
27. Coste A, Selmecki A, Forche A et al 2007) Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell 6 : 1889 1904.
28. Coste A, Crittin J, Bauser C, Rohde B Sanglard D (2009) Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system. Eukaryot Cell 8 : 1250 1267.
29. Coste AT, Karababa M, Ischer F, Bille J Sanglard D (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3 : 1639 1652.
30. Cowen LE, Nantel A, Whiteway MS, Thomas DY, Tessier DC, Kohn LM Anderson JB (2002) Population genomics of drug resistance in Candida albicans. P Natl Acad Sci USA 99 : 9284 9289.
31. Crowley JH, Leak FW Jr., Shianna KV, Tove S Parks LW (1998) A mutation in a purported regulatory gene affects control of sterol uptake in Saccharomyces cerevisiae. J Bacteriol 180 : 4177 4183.
32. Daniel JA Grant PA (2007) Multi-tasking on chromatin with the SAGA coactivator complexes. Mutat Res 618 : 135 148.
33. Davis DA, Bruno VM, Loza L, Filler SG Mitchell AP (2002) Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162 : 1573 1581.
34. De Micheli M, Bille J, Schueller C Sanglard D (2002) A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43 : 1197 1214.
35. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M Rodriguez-Tudela JL (2003) A point mutation in the 14α-sterol demethylase gene Cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Ch 47 : 1120 1124.
36. Dodgson AR, Dodgson KJ, Pujol C, Pfaller MA Soll DR (2004) Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob Agents Ch 48 : 2223 2227.
37. Douglas CM, D'Ippolito JA, Shei GJ et al 1997) Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Ch 41 : 2471 2479.
38. Dunkel N, Blass J, Rogers PD Morschhauser J (2008a) Mutations in the multidrug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol 69 : 827 840.
39. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J Rogers PD (2008b) A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot Cell 7 : 1180 1190.
40. Edlind T (2007) Emergence and evolution of antifungal resistance. Evolutionary Biology of Bacterial and Fungal Pathogens (Baquero F, Nombela C, Cassell GH Gutierrez-Fuentes JA, eds), pp. 297 306. ASM Press, Washington, DC.
41. Enjalbert B, Nantel A Whiteway M (2003) Stress-induced gene expression in Candida albicans: absence of a general stress response. Mol Biol Cell 14 : 1460 1467.
42. Espinel-Ingroff A (1997) Clinical relevance of antifungal resistance. Infect Dis Clin N Am 11 : 929 944.
43. Favre B, Didmon M Ryder NS (1999) Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans. Microbiology 145 : 2715 2725.
44. Ferrari S, Ischer F, Calabrese D et al 2009) Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 5 : e1000268.
45. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA Koltin Y (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227 : 318 329.
46. Franz R, Michel S Morschhauser J (1998) A fourth gene from the Candida albicans CDR family of ABC transporters. Gene 220 : 91 98.
47. Garcia-Effron G, Dilger A, Alcazar-Fuoli L, Park S, Mellado E Perlin DS (2008a) Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J Clin Microbiol 46 : 1200 1206.
48. Garcia-Effron G, Katiyar SK, Park S, Edlind TD Perlin DS (2008b) A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Ch 52 : 2305 2312.
49. Garcia-Effron G, Kontoyiannis DP, Lewis RE Perlin DS (2008c) Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Ch 52 : 4181 4183.
50. Gaur M, Choudhury D Prasad R (2005) Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microb Biotech 9 : 3 15.
51. Gaur M, Puri N, Manoharlal R, Rai V, Mukhopadhayay G, Choudhury D Prasad R (2008) MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9 : 579.
52. Gaur NA, Puri N, Karnani N, Mukhopadhyay G, Goswami SK Prasad R (2004) Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans. FEMS Yeast Res 4 : 389 399.
53. Gehrt A, Peter J, Pizzo PA Walsh TJ (1995) Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 33 : 1302 1307.
54. Harry JB, Oliver BG, Song JL, Silver PM, Little JT, Choiniere J White TC (2005) Drug-induced regulation of the MDR1 promoter in Candida albicans. Antimicrob Agents Ch 49 : 2785 2792.
55. Hikkel I, Lucau-Danila A, Delaveau T, Marc P, Devaux F Jacq C (2003) A general strategy to uncover transcription factor properties identifies a new regulator of drug resistance in yeast. J Biol Chem 278 : 11427 11432.
56. Hiller D, Stahl S Morschhauser J (2006) Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Antimicrob Agents Ch 50 : 2300 2308.
57. Holmes AR, Lin YH, Niimi K et al 2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Ch 52 : 3851 3862.
58. Hope WW, Tabernero L, Denning DW Anderson MJ (2004) Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob Agents Ch 48 : 4377 4386.
59. Karababa M, Coste AT, Rognon B, Bille J Sanglard D (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Ch 48 : 3064 3079.
60. Karnani N, Gaur NA, Jha S et al 2004) SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter. Yeast 21 : 219 239.
61. Katiyar S, Pfaller M Edlind T (2006) Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Ch 50 : 2892 2894.
62. Katiyar SK Edlind TD (2001) Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med Mycol 39 : 109 116.
63. Kaur R, Castano I Cormack BP (2004) Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Ch 48 : 1600 1613.
64. Kelly SL, Lamb DC, Corran AJ, Baldwin BC Kelly DE (1995) Mode of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3ß,6a-diol. Biochem Bioph Res Co 207 : 910 915.
65. Kelly SL, Lamb DC Kelly DE (1999a) Y132H substitution in Candida albicans sterol 14α-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol Lett 180 : 171 175.
66. Kelly SL, Lamb DC, Loeffler J, Einsele H Kelly DE (1999b) The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem Bioph Res Co 262 : 174 179.
67. Kolaczkowska A Goffeau A (1999) Regulation of pleiotropic drug resistance in yeast. Drug Resist Update 2 : 403 414.
68. Kolaczkowska A, Kolaczkowski M, Goffeau A Moye-Rowley WS (2008) Compensatory activation of the multidrug transporters Pdr5p, Snq2p, and Yor1p by Pdr1p in Saccharomyces cerevisiae. FEBS Lett 582 : 977 983.
69. Kolaczkowski M Goffeau A (1997) Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance. Pharmacol Therapeut 76 : 219 242.
70. Kren A, Mamnun YM, Bauer BE et al 2003) War1p, a novel transcription factor controlling weak acid stress response in yeast. Mol Cell Biol 23 : 1775 1785.
71. Kudo M, Ohi M, Aoyama Y, Nitahara Y, Chung SK Yoshida Y (2005) Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds. J Biochem 137 : 625 632.
72. Kuge S, Arita M, Murayama A, Maeta K, Izawa S, Inoue Y Nomoto A (2001) Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation. Mol Cell Biol 21 : 6139 6150.
73. LaFleur MD, Kumamoto CA Lewis K (2006) Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Ch 50 : 3839 3846.
74. Lamb DC, Kelly DE, White TC Kelly SL (2000) The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Ch 44 : 63 67.
75. Lamoureux JS, Stuart D, Tsang R, Wu C Glover JN (2002) Structure of the sporulation-specific transcription factor Ndt80 bound to DNA. EMBO J 21 : 5721 5732.
76. Lamping E, Ranchod A, Nakamura K et al 2009) Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob Agents Ch 53 : 354 369.
77. Lass-Florl C (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52 : 197 205.
78. Lavoie H, Sellam A, Askew C, Nantel A Whiteway M (2008) A toolbox for epitope-tagging and genome-wide location analysis in Candida albicans. BMC Genomics 9 : 578.
79. Lee RE, Liu TT, Barker KS Rogers PD (2005) Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans. J Antimicrob Chemoth 55 : 655 662.
80. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5 : 48 56.
81. Liu TT, Lee RE, Barker KS, Wei L, Homayouni R Rogers PD (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Ch 49 : 2226 2236.
82. Liu TT, Znaidi S, Barker KS et al 2007) Genome-wide expression and location analyses of the Candida albicans Tac1p regulon. Eukaryot Cell 6 : 2122 2138. (Pubitemid 350221281)
83. MacPherson S, Akache B, Weber S, De Deken X, Raymond M Turcotte B (2005) Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Ch 49 : 1745 1752.
84. MacPherson S, Larochelle M Turcotte B (2006) A fungal family of transcriptional regulators: the zinc cluster proteins. Microbiol Mol Biol R 70 : 583 604.
85. Mann PA, Parmegiani RM, Wei SQ et al 2003) Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14α-demethylase. Antimicrob Agents Ch 47 : 577 581.
86. Marichal P, Vanden Bossche H, Odds FC et al 1997) Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Ch 41 : 2229 2237.
87. Marichal P, Koymans L, Willemsens S et al 1999) Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145 : 2701 2713.
88. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJ, Verweij PE, Cuenca-Estrella M Rodriguez-Tudela JL (2007) A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Ch 51 : 1897 1904.
89. Mendizabal I, Rios G, Mulet JM, Serrano R de Larrinoa IF (1998) Yeast putative transcription factors involved in salt tolerance. FEBS Lett 425 : 323 328.
90. Miyazaki H, Miyazaki Y, Geber A et al 1998) Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Ch 42 : 1695 1701.
91. Mizoguchi H, Yamauchi T, Watanabe M, Yamanaka H, Nishimura A Hanamoto H (2002) Different missense mutations in PDR1 and PDR3 genes from clotrimazole-resistant sake yeast are responsible for pleiotropic drug resistance and improved fermentative activity. J Biosci Bioeng 93 : 221 227.
92. Moran G, Sullivan D, Morschhauser J Coleman D (2002) The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob Agents Ch 46 : 2829 2841.
93. Moran GP, Sanglard D, Donnelly S, Shanley DB, Sullivan DJ Coleman DC (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Ch 42 : 1819 1830.
94. Morschhauser J, Barker KS, Liu TT, Bla BWJ, Homayouni R Rogers PD (2007) The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 3 : e164.
95. Mukherjee PK, Chandra J, Kuhn DM Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71 : 4333 4340.
96. Nascimento AM, Goldman GH, Park S et al 2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Ch 47 : 1719 1726.
97. Nett J, Lincoln L, Marchillo K et al 2007) Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Ch 51 : 510 520.
98. Nguyen DT, Alarco AM Raymond M (2001) Multiple Yap1p-binding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J Biol Chem 276 : 1138 1145.
99. Niewerth M Korting HC (2000) The use of systemic antimycotics in dermatotherapy. Eur J Dermatol 10 : 155 160.
100. Noffz CS, Liedschulte V, Lengeler K Ernst JF (2008) Functional mapping of the Candida albicans Efg1 regulator. Eukaryot Cell 7 : 881 893.
101. Nourani A, Papajova D, Delahodde A, Jacq C Subik J (1997) Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain. Mol Gen Genet 256 : 397 405.
102. Oliver BG, Song JL, Choiniere JH White TC (2007) cis-acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p. Eukaryot Cell 6 : 2231 2239.
103. Park S, Kelly R, Kahn JN et al 2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Ch 49 : 3264 3273.
104. Perea S, Lopez-Ribot JL, Kirkpatrick WR et al 2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Ch 45 : 2676 2684.
105. Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Update 10 : 121 130.
106. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L et al 2008) Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 46 : 2620 2629.
107. Pinjon E, Moran GP, Jackson CJ, Kelly SL, Sanglard D, Coleman DC Sullivan DJ (2003) Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob Agents Ch 47 : 2424 2437.
108. Pinjon E, Jackson CJ, Kelly SL, Sanglard D, Moran G, Coleman DC Sullivan DJ (2005) Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob Agents Ch 49 : 1312 1318.
109. Polak A Scholer HJ (1975) Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21 : 113 130.
110. Polakova S, Blume C, Zarate JA, Mentel M, Jorck-Ramberg D, Stenderup J Piskur J (2009) Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. P Natl Acad Sci USA 106 : 2688 2693.
111. Posteraro B, Sanguinetti M, Sanglard D et al 2003) Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol 47 : 357 371.
112. Prasad R, De Wergifosse P, Goffeau A Balzi E (1995) Molecular cloning and characterisation of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27 : 320 329.
113. Prasad R, Gaur NA, Gaur M Komath SS (2006) Efflux pumps in drug resistance of Candida. Infect Disord Drug Targets 6 : 69 83.
114. Proft M, Pascual-Ahuir A, de Nadal E, Arino J, Serrano R Posas F (2001) Regulation of the Sko1 transcriptional repressor by the Hog1 MAP kinase in response to osmotic stress. EMBO J 20 : 1123 1133.
115. Raj S Edlind T (2008) Characterization of CDR1 promoter elements responsible for azole resistance in the opportunistic yeast Candida glabrata. 9th ASM Conference on Candida and Candidiasis, p. 113. ASM Press, Washington, DC.
116. Rajeswary S, Kumaran B, Ilangovan R et al 2007) Modulation of antioxidant defense system by the environmental fungicide carbendazim in Leydig cells of rats. Reprod Toxicol 24 : 371 380.
117. Ramage G, Bachmann S, Patterson TF, Wickes BL Lopez-Ribot JL (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemoth 49 : 973 980.
118. Rauceo JM, Blankenship JR, Fanning S et al 2008) Regulation of the Candida albicans cell wall damage response by transcription factor Sko1 and PAS kinase Psk1. Mol Biol Cell 19 : 2741 2751.
119. Reinoso-Martin C, Schuller C, Schuetzer-Muehlbauer M Kuchler K (2003) The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell 2 : 1200 1210.
120. Rex JH, Pfaller MA, Galgiani JN et al 1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 24 : 235 247.
121. Richardson M Lass-Florl C (2008) Changing epidemiology of systemic fungal infections. Clin Microbiol Infec 14 (suppl 4) : 5 24.
122. Riggle PJ Kumamoto CA (2006) Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site. Eukaryot Cell 5 : 1957 1968.
123. Rocha EM, Garcia-Effron G, Park S Perlin DS (2007) A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob Agents Ch 51 : 4174 4176.
124. Rodero L, Mellado E, Rodriguez AC et al 2003) G484S amino acid substitution in lanosterol 14-α demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Ch 47 : 3653 3656.
125. Rogers PD Barker KS (2002) Evaluation of differential gene expression in fluconazole susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob Agents Ch 46 : 3412 3417.
126. Rogers PD Barker KS (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Ch 47 : 1220 1227.
127. Rognon B, Kozovska Z, Coste AT, Pardini G Sanglard D (2006) Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology 152 : 3701 3722.
128. Rustad TR, Stevens DA, Pfaller MA White TC (2002) Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology 148 : 1061 1072.
129. Sa-Correia I, dos Santos SC, Teixeira MC, Cabrito TR Mira NP (2009) Drug: H+ antiporters in chemical stress response in yeast. Trends Microbiol 17 : 22 31.
130. Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5 : 379 385.
131. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M Bille J (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Ch 39 : 2378 2386.
132. Sanglard D, Ischer F, Monod M Bille J (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Ch 40 : 2300 2305.
133. Sanglard D, Ischer F, Monod M Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC-transporter gene. Microbiology 143 : 405 416.
134. Sanglard D, Ischer F, Koymans L Bille J (1998) Amino acid substitutions in the cytochrome P450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contributing to the resistance to azole antifungal agents. Antimicrob Agents Ch 42 : 241 253.
135. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA Bille J (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Ch 43 : 2753 2765.
136. Sanglard D, Ischer F Bille J (2001) Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Ch 45 : 1174 1183.
137. Sanglard D, Ischer F, Parkinson T, Falconer D Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Ch 47 : 2404 2412.
138. Schjerling P Holmberg S (1996) Comparative amino acid sequence analysis of the C6 zinc cluster family of transcriptional regulators. Nucleic Acids Res 24 : 4599 4607.
139. Schubert S, Rogers PD Morschhauser J (2008) Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Ch 52 : 4274 4280.
140. Sellam A, Askew C, Epp E, Lavoie H, Whiteway M Nantel A (2009a) Genome-wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicans. Mol Biol Cell 20 : 2389 2400.
141. Sellam A, Tebbji F Nantel A (2009b) Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans. Eukaryot Cell 8 : 1174 1183.
142. Selmecki A, Forche A Berman J (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313 : 367 370.
143. Sheehan DJ, Hitchcock CA Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12 : 40 79.
144. Shen H, An MM, Wang de J et al 2007) Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction. Biol Pharm Bull 30 : 68 73.
145. Shukla S, Saini P, Smriti, Jha S, Ambudkar SV Prasad R (2003) Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot Cell 2 : 1361 1375.
146. Shukla S, Rai V, Banerjee D Prasad R (2006) Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. Biochemistry 45 : 2425 2435.
147. Silver PM, Oliver BG White TC (2004) Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 3 : 1391 1397.
148. Sionov E, Chang YC, Garraffo HM Kwon-Chung KJ (2009) Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Ch 53 : 2804 2815.
149. Skaggs BA, Alexander JF, Pierson CA et al 1996) Cloning and characterization of the Saccharomyces cerevisiae C-22 sterol desaturase gene, encoding a second cytochrome P-450 involved in ergosterol biosynthesis. Gene 169 : 105 109.
150. Smith WL Edlind TD (2002) Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Ch 46 : 3532 3539.
151. Snelders E, van der Lee HA, Kuijpers J et al 2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5 : e219.
152. Talibi D Raymond M (1999) Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J Bacteriol 181 : 231 240.
153. Thakur JK, Arthanari H, Yang F et al 2008) A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452 : 604 609.
154. Thompson GR, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS Patterson TF (2008) Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Ch 52 : 3783 3785.
155. Thompson GR, Cadena J Patterson TF (2009) Overview of antifungal agents. Clin Chest Med 30 : 203 215.
156. Torelli R, Posteraro B, Ferrari S et al 2008) The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributor to the CgPdr1-dependent azole resistance in Candida glabrata. Mol Microbiol 68 : 186 201.
157. Tsai HF, Krol AA, Sarti KE Bennett JE (2006) Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Ch 50 : 1384 1392.
158. Tsao S, Rahkhoodaee F Raymond M (2009) Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Ch 53 : 1344 1352.
159. Vanden Bossche H, Marichal P Odds FC (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2 : 393 400.
160. Vandeputte P, Larcher G, Berges T, Renier G, Chabasse D Bouchara JP (2005) Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Ch 49 : 4608 4615.
161. Vandeputte P, Tronchin G, Berges T, Hennequin C, Chabasse D Bouchara JP (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob Agents Ch 51 : 982 990.
162. Vandeputte P, Tronchin G, Larcher G, Ernoult E, Berges T, Chabasse D Bouchara JP (2008) A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata. Antimicrob Agents Ch 52 : 3701 3709.
163. Vermitsky JP Edlind TD (2004) Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob Agents Ch 48 : 3773 3781.
164. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD Rogers PD (2006) Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 61 : 704 722.
165. Vik A Rine J (2001) Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol Cell Biol 21 : 6395 6405.
166. White TC (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Ch 41 : 1482 1487.
167. White TC, Holleman S, Dy F, Mirels LF Stevens DA (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Ch 46 : 1704 1713.
168. Wirsching S, Moran GP, Sullivan DJ, Coleman DC Morschhauser J (2001) MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Ch 45 : 3416 3421.
169. Zhang X, De Micheli M, Coleman ST, Sanglard D Moye-Rowley WS (2000) Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p. Mol Microbiol 36 : 618 629.
170. Znaidi S, De Deken X, Weber S, Rigby T, Nantel A Raymond M (2007) The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans. Mol Microbiol 66 : 440 452.
171. Znaidi S, Weber S, Al-Abdin OZ et al 2008) Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell 7 : 836 847.
172. Znaidi S, Barker KS, Weber S et al 2009) Identification of the Candida albicans Cap1p regulon. Eukaryot Cell 8 : 806 820.